Kratom Label Terms: Strain Names, Serving Directions, and What They Do Not Prove

What This Page Covers

Kratom products are sold with labels that use terms like “Red Bali,” “Green Maeng Da,” or serving amounts in grams or capsules. This page explains, in plain language, what those label terms actually mean, where they come from, and what they do not tell you. It does not recommend any product, strain, or dose, and it is not a substitute for medical advice.

Red-Flag Guidance First

If you or someone else has taken kratom and is experiencing difficulty breathing, seizures, confusion, chest pain, or loss of consciousness, call 911 or go to the nearest emergency room immediately. If you suspect an unintentional overdose or dangerous drug interaction, contact Poison Control at 1-800-222-1222 for guidance from a real person, right away.

The Plain-Language Definition

Kratom (Mitragyna speciosa) is a tropical tree native to Southeast Asia. Leaves from the tree are dried and sold as powders, capsules, or extracts. Two label elements show up on almost every kratom product:

Strain name — a marketing label, usually combining a color (red, green, white, or yellow) with a place name (Bali, Borneo, Maeng Da, Thai) or a brand-specific term.
Serving direction — an amount (often in grams, capsules, or scoops) and a suggested frequency, set by the seller.

Neither of these terms is defined or verified by a government health agency. According to the U.S. Food and Drug Administration, kratom is not lawfully marketed in the United States as a drug product, a dietary supplement, or a food additive, which means there is no FDA-reviewed standard behind any strain name or serving amount you see on a label.

What Strain Names Are Actually Based On

The color in a strain name (red, green, white) typically refers to the color of the leaf's vein at harvest, and the place name typically refers to where the tree grew or where the seller says it grew. These are supply-chain and marketing conventions set by growers and vendors — not a classification system verified by a testing agency or standards body. Two products both labeled “Red Bali” from two different sellers are not designed to deliver to be chemically similar, because there is no independent authority confirming vein color, growing region, or processing method matches what the label says.

What Strain Names Do Not Prove

They do not prove a specific effect on any individual person. Effects described anecdotally for one strain name are not the same as a clinical finding, and results vary between people and between batches.
They do not prove alkaloid content. The FDA notes kratom contains over 50 alkaloids, with most research focused on two: mitragynine and 7-hydroxymitragynine (7-OH), which the FDA describes as a naturally occurring but minor alkaloid making up less than 2% of the total alkaloid content in natural kratom leaves. No independent testing standard ties a specific alkaloid profile to a strain name, so two products carrying the same name are not designed to deliver to contain the same alkaloid mix.
They do not prove safety. A strain name says nothing about contamination, dosing accuracy, or how a batch was processed.

What Serving Directions Are Actually Based On

A “suggested serving” on a kratom label is set by the seller, not by a regulatory dosing standard. There is no FDA-approved kratom drug product and no established, agency-reviewed dosing guideline for kratom in any form. The FDA states it continues to warn consumers against using kratom because of risks including liver toxicity, seizures, and substance use disorder, and it notes that a well-designed human abuse-potential study has not yet been completed, meaning the substance's abuse potential is not yet fully understood.

What Serving Directions Do Not Prove

They do not prove a “safe” amount for any individual. A serving suggestion reflects what a seller chooses to print, not a tested safety threshold.
They do not account for individual differences such as body weight, other medications, liver or kidney function, or pregnancy. The FDA has noted cases of neonatal abstinence syndrome in newborns following prolonged prenatal kratom exposure.
They do not account for product variability. Because no independent standard verifies alkaloid content batch to batch, a printed serving size cannot commitment a consistent effect from one product to the next, even at the same gram amount.

A Worksheet for Reading Any Kratom Label

Use this worksheet as a starting point before you evaluate any kratom product label. It does not replace a conversation with a healthcare provider.

What does the strain name actually claim? Write down the color and place name exactly as printed. Ask: is there any testing certificate attached, or is this name alone?
Is there a certificate of analysis (COA)? A COA from an independent, third-party lab is different from a strain name — it is the closest thing to verification a label can offer, and its absence is itself information.
What does the serving direction claim, and who set it? Note whether the label states this is a manufacturer suggestion rather than a medically reviewed dose.
What warnings are missing? Check whether the label mentions pregnancy, drug interactions, or use in combination with other substances. FDA guidance notes kratom-related deaths have typically involved kratom combined with other drugs, where kratom's individual contribution is often unclear.
What would you ask a pharmacist or doctor before using this product? Write the specific question down (for example: “Does this interact with medication X?”) so you can ask it directly rather than relying on the label.

A Note on Legal Status

Kratom's legal status varies by state, and some states and municipalities restrict or ban it. The FDA has stated that state health and law enforcement agencies are the best resource for questions about kratom's legal status in a specific location.

Where the Facts in This Article Came From

Statements about kratom's regulatory status, risks, and current research were drawn from the FDA's public page on kratom, current as of December 2, 2025. Where a claim about individual product labels, strain-naming conventions, or serving-size practices reflects general labeling and supply-chain practice rather than a specific agency finding, that is noted in the text above.

Medical Information Disclaimer

This article is for general educational purposes only and is not medical advice, a treatment recommendation, or a substitute for care from a licensed healthcare provider. Do not start, stop, or change any medication or supplement based on this article. If you have questions about kratom use, a specific product, or a specific health condition, talk to a doctor or pharmacist. If you are experiencing a medical emergency, call 911.

Last updated: September 15, 2026. By KratomCBDDirect.com Editorial Team.